These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 15497158

  • 1. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
    Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RT.
    Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158
    [Abstract] [Full Text] [Related]

  • 2. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
    Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Sulpice L, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Cherqui D, Duvoux C.
    Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590
    [Abstract] [Full Text] [Related]

  • 3. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
    Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G.
    Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
    [Abstract] [Full Text] [Related]

  • 4. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK.
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [Abstract] [Full Text] [Related]

  • 5. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, Rosen M, Soulen M, Shaked A, Reddy KR, Olthoff KM.
    Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
    [Abstract] [Full Text] [Related]

  • 6. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study.
    Figueras J, Ibañez L, Ramos E, Jaurrieta E, Ortiz-de-Urbina J, Pardo F, Mir J, Loinaz C, Herrera L, López-Cillero P, Santoyo J.
    Liver Transpl; 2001 Oct; 7(10):877-83. PubMed ID: 11679986
    [Abstract] [Full Text] [Related]

  • 7. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria.
    Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP.
    Liver Transpl; 2002 Sep; 8(9):765-74. PubMed ID: 12200775
    [Abstract] [Full Text] [Related]

  • 8. Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era.
    Levi DM, Tzakis AG, Martin P, Nishida S, Island E, Moon J, Selvaggi G, Tekin A, Madrazo BL, Narayanan G, Garcia MT, Feun LG, Tryphonopoulos P, Skartsis N, Livingstone AS.
    J Am Coll Surg; 2010 May; 210(5):727-34, 735-6. PubMed ID: 20421039
    [Abstract] [Full Text] [Related]

  • 9. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [Abstract] [Full Text] [Related]

  • 10. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME, Koneru B, Rocca JP, Wolf DC, Kim-Schluger L, Visintainer P, Klein KM, Chun H, Marvin M, Rozenblit G, Rodriguez-Davalos M, Sheiner PA.
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [Abstract] [Full Text] [Related]

  • 11. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
    Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, Gordon F, Khwaja K, Jenkins R, Pomfret EA.
    Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
    [Abstract] [Full Text] [Related]

  • 12. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
    Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, Lipshutz G, Yersiz H, Lu DS, Lassman C, Tong MJ, Hiatt JR, Busuttil RW.
    Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454
    [Abstract] [Full Text] [Related]

  • 13. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database.
    Austin MT, Leys CM, Feurer ID, Lovvorn HN, O'Neill JA, Pinson CW, Pietsch JB.
    J Pediatr Surg; 2006 Jan; 41(1):182-6. PubMed ID: 16410130
    [Abstract] [Full Text] [Related]

  • 14. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.
    Sotiropoulos GC, Molmenti EP, Omar OS, Bockhorn M, Brokalaki EI, Lang H, Frilling A, Broelsch CE, Malagó M.
    Eur J Med Res; 2006 Nov 30; 11(11):467-70. PubMed ID: 17182358
    [Abstract] [Full Text] [Related]

  • 15. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J, Sanchez B, de la Mata M, Fernández-Aguilar JL, Lopez-Ciller P, Pascasio JM, Suarez MA, Gomez MA, Nogueras F, Muffak K, Cuende N, Alonso M.
    Transplant Proc; 2009 Apr 30; 41(3):1009-11. PubMed ID: 19376412
    [Abstract] [Full Text] [Related]

  • 16. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.
    Liver Transpl; 2007 Jun 30; 13(6):807-13. PubMed ID: 17539001
    [Abstract] [Full Text] [Related]

  • 17. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N, Neff G, Kaiser T, Zacharias V, Thomas M, Tevar A, Satwah S, Shukla R, Buell J.
    Liver Transpl; 2006 Oct 30; 12(10):1519-22. PubMed ID: 17004260
    [Abstract] [Full Text] [Related]

  • 18. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF, Molina E, Bustamante M, Tomé S, Otero E, Martínez J, Segade FR, Conde R, Varo E.
    Transplant Proc; 2008 Nov 30; 40(9):2975-7. PubMed ID: 19010164
    [Abstract] [Full Text] [Related]

  • 19. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
    Zhou J, Wang Z, Wu ZQ, Qiu SJ, Yu Y, Huang XW, Tang ZY, Fan J.
    Transplant Proc; 2008 Dec 30; 40(10):3548-53. PubMed ID: 19100435
    [Abstract] [Full Text] [Related]

  • 20. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, Kim IH, Yi NJ, Lee KU.
    Surgery; 2007 May 30; 141(5):598-609. PubMed ID: 17462459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.